Optometrists in Savannah, TN Accepting Medicare
5 Optometrists found. Showing 1 - 5
 Dr. Patrick Jones, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 285 Main St, Savannah, TN 38372 Phone: 731-925-6225 |
Jerry D Rogers Optometrist Medicare: Accepting Medicare Assignments Practice Location: 175 J I Bell Lane, Savannah, TN 38372 Phone: 731-925-4902 Fax: 731-925-4445 |
 Jerry D Rogers Optometrist Medicare: Not Enrolled in Medicare Practice Location: 175 Ji Bell Ln, Savannah, TN 38372 Phone: 731-925-4902 Fax: 731-925-4445 |
Richard N Rogers, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 285 Main St, Savannah, TN 38372 Phone: 731-925-6225 Fax: 731-925-0235 |
Rogers Eye Center Pc Optometrist Medicare: Medicare Enrolled Practice Location: 285 Main St, Savannah, TN 38372 Phone: 731-925-6225 Fax: 731-925-0235 |
News Archive
Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
In people infected with human immunodeficiency virus (HIV), highly active anti-retroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.
Asthma medication adherence strategies identified
Keeping asthma medication in the bathroom and incorporating its use into daily routines are strategies associated with good medication adherence in older adults with asthma, US research shows.
Protein-RNA interactions in SARS-CoV-2-infected cells reveal key regulators of infection
Researchers in the UK, including the University of Oxford and Glasgow, as well as the University of Heidelberg, published their analysis of protein-RNA interactions in SARS-CoV-2 and the subsequent significance in the journal Molecular Cell. This research could help to uncover novel antiviral strategies for COVID-19 due to a broader understanding of how the virus works.
One in 110 American children suffer from ASD, shows study
Autism and related development disorders are becoming more common, with a prevalence rate approaching 1 percent among American 8-year-olds, according to new data from researchers at the University of Alabama at Birmingham (UAB) School of Public Health and the Centers for Disease Control and Prevention (CDC).
Treating metastatic melanoma tumors with specific genetic signature shows promising results
Use of an experimental targeted drug to treat metastatic melanoma tumors with a specific genetic signature was successful in more than 80 percent of patients in a phase 1 clinical trial.
› Verified 5 days ago
Physical Therapists
Chiropractors
Optometrists
Occupational Therapists
Podiatrists
Speech-Language Pathologists